meibomask®

meibomask® is a professional-use Class II medical device focused on anterior-segment care. It is a distinct device in its own right, not a mask accessory of another system, designed for clinicians who want a focused, lower-footprint tool for the ocular surface and eyelids rather than the full dual-modality breadth of eye-light®.

What it does

meibomask® delivers light-based therapy to the eyelids and ocular surface, supporting meibomian gland function and the stability of the tear film. Where available, it supports blue and red wavelength masks, allowing the clinician to target the lid margin and the gland-related drivers of dry eye and meibomian gland dysfunction.

Who it is for

meibomask® is positioned for surgeons and clinicians who need anterior-segment care, including ocular surface preparation ahead of surgery. With a smaller footprint, a narrower feature set and a lower price point than eye-light®, it suits practices whose primary need is ocular surface optimisation rather than the posterior-segment and full-protocol capabilities of the flagship.

How it compares within the line-up

meibomask® sits between the home-use my-mask® and the professional flagship eye-light®. It is a professional device, so it is operated in the clinic under professional oversight, but it is purpose-built for anterior-segment work rather than the complete anterior-and-posterior solution.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.